Handelsbanken Fonder’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Handelsbanken Fonder’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-62,900	Closed	-$8.57M	–	1563
2020 Q3	$8.57M	Buy	62,900 +3,500	+6%	+$372K	0.06%	266
2020 Q2	$5.74M	Buy	59,400 +6,400	+12%	+$534K	0.05%	308
2020 Q1	$2.48M	Hold	53,000	–	–	0.05%	159
2019 Q4	$3.86M	Hold	53,000	–	–	0.07%	160
2019 Q3	$2.76M	Buy	53,000 +10,000	+23%	+$532K	0.06%	160
2019 Q2	$2.16M	Sell	43,000 -10,000	-19%	-$487K	0.04%	170
2019 Q1	$2.75M	Hold	53,000	–	–	0.05%	163
2018 Q4	$2.59M	Sell	53,000 -10,000	-16%	-$550K	0.05%	154
2018 Q3	$4.11M	Buy	63,000 +10,000	+19%	+$588K	0.08%	153
2018 Q2	$2.63M	Buy	53,000 +20,000	+61%	+$968K	0.05%	166
2018 Q1	$1.61M	Buy	33,000 +5,000	+18%	+$260K	0.03%	174
2017 Q4	$1.18M	Buy	28,000 +13,000	+87%	+$501K	0.03%	163
2017 Q3	$643K	Buy	+15,000	New	+$479K	0.01%	174

Handelsbanken Fonder's MYOK Position: Q4 2020 in Review

Handelsbanken Fonder sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 62,900 shares — an estimated $8.57M sold.

Handelsbanken Fonder first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $8.57M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Handelsbanken Fonder reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Handelsbanken Fonder sold 62,900 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $8.57M.
Handelsbanken Fonder first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
Handelsbanken Fonder's MyoKardia, Inc. Common Stock position peaked at $8.57M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.